{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:01:25Z","timestamp":1784858485636,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100015979","name":"Pelotonia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Anusandhan National research foundation","doi-asserted-by":"crossref","award":["India"],"award-info":[{"award-number":["India"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-00975-3","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:12:17Z","timestamp":1784855537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying the angiogenic receptor expression in mantle cell lymphoma patients and murine models"],"prefix":"10.1186","volume":"14","author":[{"given":"Satishkumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuvrat","family":"Sircar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udita","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura","family":"Srour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"La Ferlita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Distefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astha","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German J.","family":"Peralta-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedieh","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob C.","family":"Holter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Tinapple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Barlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaliqur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Nezati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam Kumar","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvathi","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natarajan","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Baiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lapo","family":"Alinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-3579","authenticated-orcid":false,"given":"Blake R.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-3457","authenticated-orcid":false,"given":"Narendranath","family":"Epperla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3736-8621","authenticated-orcid":false,"given":"Neeraj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1151-5427","authenticated-orcid":false,"given":"Lalit","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"975_CR1","doi-asserted-by":"publisher","first-page":"100744","DOI":"10.1016\/j.tranon.2020.100744","volume":"13","author":"T Annese","year":"2020","unstructured":"Annese T, et al. Inflammatory Infiltrate and Angiogenesis in Mantle Cell Lymphoma. Transl Oncol. 2020;13:100744.","journal-title":"Transl Oncol"},{"key":"975_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.semcancer.2011.09.006","volume":"21","author":"JA Burger","year":"2011","unstructured":"Burger JA, Ford RJ. The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapies. Semin Cancer Biol. 2011;21:308\u201312.","journal-title":"Semin Cancer Biol"},{"key":"975_CR3","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1080\/10428194.2022.2086244","volume":"63","author":"D Qualls","year":"2022","unstructured":"Qualls D, Kumar A, Epstein-Peterson ZD. Targeting the immune microenvironment in mantle cell lymphoma: implications for current and emerging therapies. Leuk Lymphoma. 2022;63:2515\u201327.","journal-title":"Leuk Lymphoma"},{"key":"975_CR4","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood-2014-04-569566","volume":"124","author":"J Palomero","year":"2014","unstructured":"Palomero J, et al. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma. Blood. 2014;124:2235\u201347.","journal-title":"Blood"},{"key":"975_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neo.2016.11.008","volume":"19","author":"F Guffanti","year":"2017","unstructured":"Guffanti F, et al. In Vitro and In Vivo Activity of Lucitanib in FGFR1\/2 Amplified or Mutated Cancer Models. Neoplasia. 2017;19:35\u201342.","journal-title":"Neoplasia"},{"key":"975_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2045-824X-6-18","volume":"6","author":"Y Yamamoto","year":"2014","unstructured":"Yamamoto Y, et al. Lenvatinib, an angiogenesis inhibitor targeting VEGFR\/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage. Vasc Cell. 2014;6:18.","journal-title":"Vasc Cell"},{"key":"975_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1021\/jacs.3c07488","volume":"146","author":"Y Yin","year":"2024","unstructured":"Yin Y, et al. Quantification of Binding of Small Molecules to Native Proteins Overexpressed in Living Cells. J Am Chem Soc. 2024;146:187\u2013200.","journal-title":"J Am Chem Soc"},{"key":"975_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, et al. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Therapy. 2025;10:170.","journal-title":"Signal Transduct Target Therapy"},{"key":"975_CR9","doi-asserted-by":"crossref","unstructured":"Jafari H, et al. The novel immunocompetent E\u00b5-SOX11CCND1 mouse model phenotypically and molecularly resembles human mantle cell lymphoma. Clin Cancer Res. 2025.","DOI":"10.1158\/1078-0432.c.8126028"},{"key":"975_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12272-025-01545-1","volume":"48","author":"FH Shah","year":"2025","unstructured":"Shah FH, et al. Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance. Arch Pharm Res. 2025;48:404\u201325.","journal-title":"Arch Pharm Res"},{"key":"975_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41408-025-01333-6","volume":"15","author":"A De Bol\u00f2s","year":"2025","unstructured":"De Bol\u00f2s A, et al. The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma. Blood Cancer J. 2025;15:127.","journal-title":"Blood Cancer J"},{"key":"975_CR12","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1038\/s41375-023-02006-8","volume":"37","author":"A Sircar","year":"2023","unstructured":"Sircar A, et al. Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma. Leukemia. 2023;37:2094\u2013106.","journal-title":"Leukemia"},{"key":"975_CR13","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1038\/s41375-024-02344-1","volume":"38","author":"U Jindal","year":"2024","unstructured":"Jindal U, et al. Targeting CERS6-AS1\/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma. Leukemia. 2024;38:2196\u2013209.","journal-title":"Leukemia"},{"key":"975_CR14","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1182\/blood.2020005123","volume":"136","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, et al. Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome. Blood. 2020;136:1980\u20133.","journal-title":"Blood"},{"key":"975_CR15","doi-asserted-by":"publisher","first-page":"e13009","DOI":"10.1111\/cpr.13009","volume":"54","author":"G Liu","year":"2021","unstructured":"Liu G, et al. Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment. Cell Prolif. 2021;54:e13009.","journal-title":"Cell Prolif"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00975-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00975-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00975-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:12:19Z","timestamp":1784855539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00975-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["975"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00975-3","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Samples were collected with informed consent from patients and in accordance with the Declaration of Helsinki and approval by the institutional human ethical review board of CSIR-Central Drug Research Institute (CDRI), Lucknow (CDRI\/IEC\/2023\/PA11, CDRI\/IEC\/2023\/PA12, CDRI\/IEC\/2023\/PA13) (25th October 2022) and the Ohio State University.","order":1,"name":"Ethics","label":"Ethics approval and consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final version of the manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional (CSIR-CDRI) communication number for this article is 11185.","order":3,"name":"Ethics","label":"Footnote","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.A.B. received research support from Prelude Therapeutics and serves on the SAB for Sobi, Pierre Fabre, and Atara Therapeutics. J.W.S. is a co-founder and shareholder of EMBioSys, Inc. S.P. has research support from Amgen, Celgene\/Bristol Myers Squibb Corporation, Regeneron, Genentech, imCORE, and Caribou, and serves as a consultant for Grail (advisory board). L.S. serves as a consultant for the Institute for Follicular Lymphoma Innovation. N.E. Research funding (to the institution) from Lilly, Incyte, ADC Therapeutics, Ipsen, Beigene, Advisory Board for CRISPR Therapeutics, Ipsen, Genetech. A.S. is employed and a shareholder at Astrazeneca. The remaining authors declare that they have no competing financial interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"84"}}